BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9918119)

  • 41. The Janus protein tyrosine kinases in hematopoietic cytokine signaling.
    Ihle JN
    Semin Immunol; 1995 Aug; 7(4):247-54. PubMed ID: 8520029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential roles of SOCS family members in EpoR signal transduction.
    Jegalian AG; Wu H
    J Interferon Cytokine Res; 2002 Aug; 22(8):853-60. PubMed ID: 12396724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH.
    Miquet JG; Sotelo AI; Bartke A; Turyn D
    Endocrinology; 2004 Jun; 145(6):2824-32. PubMed ID: 15016718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The CIS/SOCS proteins: a family of cytokine-inducible regulators of signaling.
    Gisselbrecht S
    Eur Cytokine Netw; 1999 Dec; 10(4):463-70. PubMed ID: 10586112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
    Cooney RN
    Shock; 2002 Feb; 17(2):83-90. PubMed ID: 11837794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Advances in basic research on Janus kinase/signal transducer and activators of transcription pathway and sepsis].
    Wang SB; Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Nov; 15(11):690-3. PubMed ID: 14604492
    [No Abstract]   [Full Text] [Related]  

  • 47. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
    Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
    Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.
    Zhang JG; Farley A; Nicholson SE; Willson TA; Zugaro LM; Simpson RJ; Moritz RL; Cary D; Richardson R; Hausmann G; Kile BT; Kent SB; Alexander WS; Metcalf D; Hilton DJ; Nicola NA; Baca M
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2071-6. PubMed ID: 10051596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes.
    Yamasaki K; Hanakawa Y; Tokumaru S; Shirakata Y; Sayama K; Hanada T; Yoshimura A; Hashimoto K
    J Invest Dermatol; 2003 Apr; 120(4):571-80. PubMed ID: 12648219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells.
    Levy JB; Schindler C; Raz R; Levy DE; Baron R; Horowitz MC
    Endocrinology; 1996 Apr; 137(4):1159-65. PubMed ID: 8625884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Negative regulators of cytokine signaling.
    Kile BT; Nicola NA; Alexander WS
    Int J Hematol; 2001 Apr; 73(3):292-8. PubMed ID: 11345194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The JAK-STAT signaling pathway and its role in oncogenesis, immunomodulation and development].
    Duarte RF; Frank DA
    Med Clin (Barc); 2000 Feb; 114(6):227-34. PubMed ID: 10757107
    [No Abstract]   [Full Text] [Related]  

  • 54. Negative regulation of cytokine signaling and inflammatory diseases.
    Inagaki-Ohara K; Hanada T; Yoshimura A
    Curr Opin Pharmacol; 2003 Aug; 3(4):435-42. PubMed ID: 12901954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease.
    Greenhalgh CJ; Miller ME; Hilton DJ; Lund PK
    Gastroenterology; 2002 Dec; 123(6):2064-81. PubMed ID: 12454862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
    Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
    Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Signaling by the cytokine receptor superfamily: JAKs and STATs.
    Ihle JN; Witthuhn BA; Quelle FW; Yamamoto K; Thierfelder WE; Kreider B; Silvennoinen O
    Trends Biochem Sci; 1994 May; 19(5):222-7. PubMed ID: 8048164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Jaks and Stats in cytokine signaling.
    Ihle JN; Nosaka T; Thierfelder W; Quelle FW; Shimoda K
    Stem Cells; 1997; 15 Suppl 1():105-11; discussion 112. PubMed ID: 9368330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor.
    Guo D; Dunbar JD; Yang CH; Pfeffer LM; Donner DB
    J Immunol; 1998 Mar; 160(6):2742-50. PubMed ID: 9510175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.